Marker of the Month | Creatinine

We explore known & novel associations of creatinine using Sapient’s DynamiQ™ Insights Engine. See what we find.

Sapient Launches Next-Generation FFPE Proteomics Platform to Unlock New Functional Insights from Archived Tissue

Enabling measure of 10K+ proteins in FFPE tissue & tumors and multi-omic molecular mapping of tumor biology.

Next-Generation FFPE Proteomics

Unlocking functional tumor biology from FFPE tissue – quantitatively, reproducibly, and at scale.

Mind the Gaps: The Real Impact of Missing Data and Outliers in Biocomputational Analysis

Sharing analytical strategies to ensure omics datasets generate insights that are both truthful & actionable.

Sapient Bioanalytics awarded two U.S. patents for its novel machine learning-powered mass spectrometry (MS) methodologies

The innovations enhance how MS data is processed, filtered & interpreted across large-scale biological datasets.

NULISAqpcr™ BD-pTau217 Assay

The only single-plex solution to offer absolute quantitation of brain-derived pTau217 in plasma.

From Lab to Launch Podcast: “The proof is in the protein”

Dr. Jonathan Usuka shares how Sapient is helping reshape how biopharma brings life-changing therapies to patients.

The INsight Quarterly Newsletter: September 2025

Keep abreast of the latest news in the field of multi-omics, with resources highlighting the impact of these advances.

Protocol: the International Milk Composition (IMiC) Consortium – a harmonized secondary analysis of human milk from four studies

Describing an untargeted metabolomics analysis protocol to explore metabolites that may contribute to infant growth.

Bioanalysis Zone Feature: Scaling biomarker discovery—more data, deeper insights

Bridging the gap from large-scale omics data generation to deep characterization of disease & treatment biomarkers.